Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2181 (LINC02181)

Target: LINC02181
Molecular classification: Long intergenic non-coding RNA (lincRNA), Long non-coding RNA (lncRNA) [lincRNAs are a subfamily]

Overview

Long intergenic non-protein coding RNA 2181 (LINC02181) is a human lincRNA gene, defined as producing autonomously transcribed non-coding RNA longer than 200 nucleotides that do not overlap any coding genes. LINC02181 is catalogued in databases such as NCBI Gene (Gene ID: 440390) and Ensembl (ENSG00000232190). LincRNAs in general have diverse biological roles including the regulation of chromatin architecture, RNA stabilization, and fine-tuning of transcription, typically in a tissue-specific manner. They may function in cis (on neighboring genes) or in trans (on distant loci). Only a small fraction of annotated lincRNAs have been functionally characterized, and there is no published evidence for LINC02181 as a therapeutic molecular target, in clinical biomarker use, or in direct disease association.

Other names: LINC02181

Biological functions

Chromatin and genome architecture remodeling (general for lincRNAs)RNA stabilizationTranscription regulation (including enhancer-associated activity)Potential tissue-specific gene expression modulationOther (functions are context-dependent and vary widely among lincRNAs)

Disease associations

Other (some lincRNAs are implicated in diseases; no evidence found for LINC02181 in cancer, inflammation, neurodegeneration, cardiovascular disease, infection, or other common categories)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2181 (LINC02181).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2181 (LINC02181).

Explore the full profile